Inventor
FLYNN PETER
US21 patents
⚠️ This page may combine multiple inventors who share the name “FLYNN PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FATE THERAPEUTICS INC
6 patentsUS10954529B2Mar 23, 2021
Minimal volume reprogramming of mononuclear cells
FATE THERAPEUTICS INC8 citations84
US10023879B2Jul 17, 2018
Minimal volume reprogramming of mononuclear cells
FATE THERAPEUTICS INC13 citations84
US10844356B2Nov 24, 2020
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
FATE THERAPEUTICS INC7 citations83
US11268069B2Mar 8, 2022
Reprogramming methods and cell culture platforms
FATE THERAPEUTICS INC4 citations70
US12264322B2Apr 1, 2025
Minimal volume reprogramming of mononuclear cells
FATE THERAPEUTICS INC0 citations62
US12415989B2Sep 16, 2025
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
FATE THERAPEUTICS INC0 citations61
UNIV YALE
4 patentsUS10273311B2Apr 30, 2019
Compositions to regulate renalase in the treatment of diseases and disorders
UNIV YALE1 citations70
US12152085B2Nov 26, 2024
Compositions and methods to regulate Renalase in the treatment of cancer
UNIV YALE0 citations59
US11370846B2Jun 28, 2022
Compositions and methods to regulate Renalase in the treatment of cancer
UNIV YALE0 citations59
US10618975B2Apr 14, 2020
Antibody to Renalase
UNIV YALE0 citations49